164 related articles for article (PubMed ID: 17266536)
21. The Nociceptin/Orphanin FQ peptide receptor antagonist, SB-612111, improves cerebral blood flow in a rat model of traumatic brain injury.
Al Yacoub ON; Tarantini S; Zhang Y; Csiszar A; Standifer KM
Front Pharmacol; 2023; 14():1272969. PubMed ID: 37920208
[TBL] [Abstract][Full Text] [Related]
22. Effects of NOP-Related Ligands in Nonhuman Primates.
Kiguchi N; Ko MC
Handb Exp Pharmacol; 2019; 254():323-343. PubMed ID: 30879202
[TBL] [Abstract][Full Text] [Related]
23. Acute single non-sedative doses of NOP receptor agonists affect acquisition of object location memory but repeated high doses do not induce long-lasting deficits.
D'Oliveira da Silva F; Zaveri NT; Moulédous L
Neurobiol Learn Mem; 2023 Nov; 205():107841. PubMed ID: 37832816
[TBL] [Abstract][Full Text] [Related]
24. Nociceptin/orphanin FQ opioid receptor (NOP) selective ligand MCOPPB links anxiolytic and senolytic effects.
Raffaele M; Kovacovicova K; Biagini T; Lo Re O; Frohlich J; Giallongo S; Nhan JD; Giannone AG; Cabibi D; Ivanov M; Tonchev AB; Mistrik M; Lacey M; Dzubak P; Gurska S; Hajduch M; Bartek J; Mazza T; Micale V; Curran SP; Vinciguerra M
Geroscience; 2022 Feb; 44(1):463-483. PubMed ID: 34820764
[TBL] [Abstract][Full Text] [Related]
25. Targeting Nociceptin/Orphanin FQ receptor to rescue cognitive symptoms in a mouse neuroendocrine model of chronic stress.
D'Oliveira da Silva F; Robert C; Lardant E; Pizzano C; Bruchas MR; Guiard BP; Chauveau F; Moulédous L
Mol Psychiatry; 2023 Dec; ():. PubMed ID: 38123728
[TBL] [Abstract][Full Text] [Related]
26. Nociceptin receptor antagonist SB 612111 decreases high fat diet binge eating.
Hardaway JA; Jensen J; Kim M; Mazzone CM; Sugam JA; Diberto JF; Lowery-Gionta EG; Hwa LS; Pleil KE; Bulik CM; Kash TL
Behav Brain Res; 2016 Jul; 307():25-34. PubMed ID: 27036650
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography.
Pike VW; Rash KS; Chen Z; Pedregal C; Statnick MA; Kimura Y; Hong J; Zoghbi SS; Fujita M; Toledo MA; Diaz N; Gackenheimer SL; Tauscher JT; Barth VN; Innis RB
J Med Chem; 2011 Apr; 54(8):2687-700. PubMed ID: 21438532
[TBL] [Abstract][Full Text] [Related]
28. Development of a genetically encoded sensor for probing endogenous nociceptin opioid peptide release.
Zhou X; Stine C; Prada PO; Fusca D; Assoumou K; Dernic J; Bhat MA; Achanta AS; Johnson JC; Pasqualini AL; Jadhav S; Bauder CA; Steuernagel L; Ravotto L; Benke D; Weber B; Suko A; Palmiter RD; Stoeber M; Kloppenburg P; Brüning JC; Bruchas MR; Patriarchi T
bioRxiv; 2024 May; ():. PubMed ID: 37292957
[TBL] [Abstract][Full Text] [Related]
29. (L)-Monomethyl Tyrosine (Mmt): New Synthetic Strategy via Bulky 'Forced-Traceless' Regioselective Pd-Catalyzed C(sp
Illuminati D; Trapella C; Zanirato V; Guerrini R; Albanese V; Sturaro C; Stragapede S; Malfacini D; Compagnin G; Catani M; Fantinati A
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004457
[TBL] [Abstract][Full Text] [Related]
30. Corrigendum to "Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: are astrocytes the crossroad?" [Eur. J. Pharmacol. 823 (2018) 79-86].
Micheli L; Lucarini E; Corti F; Ciccocioppo R; Calò G; Rizzi A; Ghelardini C; Di Cesare Mannelli L
Eur J Pharmacol; 2024 May; 970():176497. PubMed ID: 38499455
[No Abstract] [Full Text] [Related]
31. Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.
Donica CL; Awwad HO; Thakker DR; Standifer KM
Mol Pharmacol; 2013 May; 83(5):907-18. PubMed ID: 23395957
[TBL] [Abstract][Full Text] [Related]
32. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic.
Thompson AA; Liu W; Chun E; Katritch V; Wu H; Vardy E; Huang XP; Trapella C; Guerrini R; Calo G; Roth BL; Cherezov V; Stevens RC
Nature; 2012 May; 485(7398):395-9. PubMed ID: 22596163
[TBL] [Abstract][Full Text] [Related]
33. The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential.
Lambert DG
Nat Rev Drug Discov; 2008 Aug; 7(8):694-710. PubMed ID: 18670432
[TBL] [Abstract][Full Text] [Related]
34. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
[TBL] [Abstract][Full Text] [Related]
35. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization.
Mollereau C; Parmentier M; Mailleux P; Butour JL; Moisand C; Chalon P; Caput D; Vassart G; Meunier JC
FEBS Lett; 1994 Mar; 341(1):33-8. PubMed ID: 8137918
[TBL] [Abstract][Full Text] [Related]
36. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
Khroyan TV; Polgar WE; Jiang F; Zaveri NT; Toll L
J Pharmacol Exp Ther; 2009 Dec; 331(3):946-53. PubMed ID: 19713488
[TBL] [Abstract][Full Text] [Related]
37. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.
Meunier JC
Eur J Pharmacol; 1997 Dec; 340(1):1-15. PubMed ID: 9527501
[TBL] [Abstract][Full Text] [Related]
38. Spotlight on Nociceptin/Orphanin FQ Receptor in the Treatment of Pain.
El Daibani A; Che T
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163856
[TBL] [Abstract][Full Text] [Related]
39. MOP and NOP receptor interaction: Studies with a dual expression system and bivalent peptide ligands.
Bird MF; McDonald J; Horley B; O'Doherty JP; Fraser B; Gibson CL; Guerrini R; Caló G; Lambert DG
PLoS One; 2022; 17(1):e0260880. PubMed ID: 35061679
[TBL] [Abstract][Full Text] [Related]
40. The NOP Receptor System in Neurological and Psychiatric Disorders: Discrepancies, Peculiarities and Clinical Progress in Developing Targeted Therapies.
Toll L; Cippitelli A; Ozawa A
CNS Drugs; 2021 Jun; 35(6):591-607. PubMed ID: 34057709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
